Literature DB >> 26738195

Pan-cancer analysis for studying cancer stage using protein expression data.

Sameer Mishra, Chanchala D Kaddi, May D Wang.   

Abstract

Pan-cancer analyses attempt to discover similar features among multiple cancers in order to identify fundamental patterns common to cancer development and progression. Pan-cancer analysis at the level of protein expression is particularly important because protein expression is more immediately related to patient phenotype than genomic or transcriptomic data. This study aims to analyze differentially expressed (DE) proteins between early and advanced cases of multiple cancer types through the usage of reverse-phase protein array data. The relevance of these proteins is further investigated by developing predictive models using K-nearest neighbor and linear discriminant analysis classifiers. The results of this study suggest that a pan-cancer analysis may be highly complementary to standard analysis of an individual cancer for identifying biologically relevant DE proteins, and can assist in developing effective predictive models for cancer progression.

Entities:  

Mesh:

Year:  2015        PMID: 26738195      PMCID: PMC4983429          DOI: 10.1109/EMBC.2015.7320295

Source DB:  PubMed          Journal:  Conf Proc IEEE Eng Med Biol Soc        ISSN: 1557-170X


  15 in total

1.  Inhibiting JNK dephosphorylation and induction of apoptosis by novel anticancer agent NSC-741909 in cancer cells.

Authors:  Xiaoli Wei; Wei Guo; Shuhong Wu; Li Wang; Yiling Lu; Bo Xu; Jinsong Liu; Bingliang Fang
Journal:  J Biol Chem       Date:  2009-05-04       Impact factor: 5.157

2.  The Akt pathway in human breast cancer: a tissue-array-based analysis.

Authors:  Shikha Bose; Sindhu Chandran; James M Mirocha; Namrata Bose
Journal:  Mod Pathol       Date:  2006-02       Impact factor: 7.842

3.  Progesterone receptor in non-small cell lung cancer--a potent prognostic factor and possible target for endocrine therapy.

Authors:  Hironori Ishibashi; Takashi Suzuki; Satoshi Suzuki; Hiromichi Niikawa; Liangying Lu; Yasuhiro Miki; Takuya Moriya; Shin-Ichi Hayashi; Masashi Handa; Takashi Kondo; Hironobu Sasano
Journal:  Cancer Res       Date:  2005-07-15       Impact factor: 12.701

4.  Detection of recurrent alternative splicing switches in tumor samples reveals novel signatures of cancer.

Authors:  Endre Sebestyén; Michał Zawisza; Eduardo Eyras
Journal:  Nucleic Acids Res       Date:  2015-01-10       Impact factor: 16.971

Review 5.  The PI3K/Akt/mTOR axis in head and neck cancer: functions, aberrations, cross-talk, and therapies.

Authors:  R Vander Broek; S Mohan; D F Eytan; Z Chen; C Van Waes
Journal:  Oral Dis       Date:  2013-12-23       Impact factor: 3.511

6.  The Human Protein Atlas--a tool for pathology.

Authors:  F Pontén; K Jirström; M Uhlen
Journal:  J Pathol       Date:  2008-12       Impact factor: 7.996

7.  Aberrant expression of proteins involved in signal transduction and DNA repair pathways in lung cancer and their association with clinical parameters.

Authors:  Yong He; Zhen Zhou; Wayne L Hofstetter; Yanbin Zhou; Wenxian Hu; Chengcheng Guo; Li Wang; Wei Guo; Apar Pataer; Arlene M Correa; Yiling Lu; Jing Wang; Lixia Diao; Lauren Averett Byers; Ignacio I Wistuba; Jack A Roth; Stephen G Swisher; John V Heymach; Bingliang Fang
Journal:  PLoS One       Date:  2012-02-10       Impact factor: 3.240

8.  The mutational landscape of phosphorylation signaling in cancer.

Authors:  Jüri Reimand; Omar Wagih; Gary D Bader
Journal:  Sci Rep       Date:  2013-10-02       Impact factor: 4.379

9.  Exploring TCGA Pan-Cancer data at the UCSC Cancer Genomics Browser.

Authors:  Melissa S Cline; Brian Craft; Teresa Swatloski; Mary Goldman; Singer Ma; David Haussler; Jingchun Zhu
Journal:  Sci Rep       Date:  2013-10-02       Impact factor: 4.379

10.  TCPA: a resource for cancer functional proteomics data.

Authors:  Jun Li; Yiling Lu; Rehan Akbani; Zhenlin Ju; Paul L Roebuck; Wenbin Liu; Ji-Yeon Yang; Bradley M Broom; Roeland G W Verhaak; David W Kane; Chris Wakefield; John N Weinstein; Gordon B Mills; Han Liang
Journal:  Nat Methods       Date:  2013-09-15       Impact factor: 28.547

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.